Koeleman B P, van Rumpt D, Hamulyák K, Reitsma P H, Bertina R M
Hemostasis and Thrombosis Research Center, Department of Hematology, University Hospital, Leiden.
Thromb Haemost. 1995 Aug;74(2):580-3.
We recently reported a high prevalence of the FV Leiden mutation (R506Q, responsible for Activated Protein C resistance) among symptomatic protein C deficient probands (19%), and the involvement of the FV Leiden mutation in the expression of thrombophilia in six protein C deficient families. Here, we report the results of a similar study in protein S deficient probands and families. Among 16 symptomatic protein S deficient probands the prevalence of the FV Leiden mutation was high (38%). This high prevalence is significantly different from that in the normal population, and is probably caused by the selection of probands for familial thrombosis and protein S deficiency. In 4 families, the segregation of the FV Leiden mutation and the protein S deficiency could be studied. In sibships where both abnormalities were segregating, the percentage of symptomatic individuals with both abnormalities was 80%. Three of the seven subjects with only the FV Leiden mutation, and two out of the three subjects with only protein S deficiency had developed thrombosis. These results indicate that in the families presented here the combination of the FV Leiden mutation and the protein S deficiency is associated with a high risk for thrombosis. A reliable estimate of the penetrance of the single defects is not possible, because the number of individuals with a single defect is too low.
我们最近报道了在有症状的蛋白C缺乏先证者中FV莱顿突变(R506Q,导致活化蛋白C抵抗)的高患病率(19%),以及FV莱顿突变在6个蛋白C缺乏家族的血栓形成倾向表达中的作用。在此,我们报告了一项针对蛋白S缺乏先证者及其家族的类似研究结果。在16名有症状的蛋白S缺乏先证者中,FV莱顿突变的患病率很高(38%)。这种高患病率与正常人群有显著差异,可能是由于对家族性血栓形成和蛋白S缺乏先证者的选择所致。在4个家族中,可以研究FV莱顿突变与蛋白S缺乏的分离情况。在两种异常均分离的同胞关系中,同时有两种异常的有症状个体的比例为80%。仅携带FV莱顿突变的7名受试者中有3名,仅蛋白S缺乏的3名受试者中有2名发生了血栓形成。这些结果表明,在此处呈现的家族中,FV莱顿突变与蛋白S缺乏的组合与血栓形成的高风险相关。由于单一缺陷个体的数量过少,无法对单一缺陷的外显率进行可靠估计。